Quidel | QDEL - Cash And Equivalent



Quidel reported $151.7M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Abbott USD 6.95B 419M Jun/2025
Agilent USD 1.54B 49M Jul/2025
Avanos Medical USD 90.3M 6.7M Jun/2025
Becton, Dickinson and Co. USD 735M 68M Jun/2025
Bruker USD 92M 92.2M Jun/2025
Charles River Laboratories USD 182.82M 46.53M Jun/2025
Danaher USD 2.96B 964M Jun/2025
Exact Sciences USD 657.1M 650.98M Jun/2025
Haemonetics USD 292.9M 13.86M Jun/2025
Hologic USD 1.74B 305.7M Jun/2025
Illumina USD 934M 179M Jun/2025
IQVIA Holdings USD 2.04B 299M Jun/2025
Merit Medical Systems USD 341.82M 53.71M Jun/2025
Mettler Toledo International USD 61.82M 2.47M Jun/2025
Myriad Genetics USD 91.8M 10.6M Mar/2025
Neogen USD 129M 1.3M May/2025
Quidel USD 151.7M 24.6M Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
STAAR Surgical USD 167.13M 5.98M Jun/2025
Thermo Fisher Scientific USD 4.58B 442M Jun/2025
Waters USD 367.22M 15.66M Jun/2025